Get my own profile
Public access
View all18 articles
1 article
available
not available
Based on funding mandates
Co-authors
Silvia BuonamiciConsultant Third Rock VenturesVerified email at thirdrockventures.com
Anant Akash AgrawalRemix TherapeuticsVerified email at remixtx.com
Shridar GanesanProfessor of Medicine, Rutgers Cancer Institute of New JerseyVerified email at cinj.rutgers.edu
Anupama ReddyData Scientist | Co-founder @ Vindhya Data ScienceVerified email at vindhyadatascience.com
James PalacinoHead of Biology, Orum TherapeuticsVerified email at orumrx.com
Frederic VaillancourtSVP, Head of Early Research, Remix TherapeuticsVerified email at remixtx.com
Benjamin L. EbertDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
Peter Fekkes54gene, HotSpot Therapeutics, H3 Biomedicine, Novartis, UC San Diego, University of GroningenVerified email at 54gene.com
George VassiliouProfessor of Haematological Medicine, University of Cambridge & Cambridge Stem Cell InstituteVerified email at sanger.ac.uk
Shouyong PengData Scientist, H3 BiomedicineVerified email at h3biomedicine.com
Annalisa MupoScientific Programme ManagerVerified email at altoslabs.com
Chia-Ling HuangNovartis Institutes of Biomedical ResearchVerified email at bu.edu
Zuzana TothovaDana-Farber Cancer Institute, Broad InstituteVerified email at broadinstitute.org
Peter SmithUniversity of SunderlandVerified email at sunderland.ac.uk
Jinesh GheeyaThe Ohio State UniversityVerified email at osumc.edu
Bryan M. DunyakRemix TherapeuticsVerified email at remixtx.com
Katsuhiro TogamiMedical oncology, Dana-Farbar Cancer InstitutionVerified email at dfci.harvard.edu
Andrew A. Lane, MD, PhDDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
Stanley Chun-Wei LeeFred Hutchinson Cancer CenterVerified email at fredhutch.org
Jesper L.V. MaagRemix TherapeuticsVerified email at remixtx.com